Why the study?
Does the neutrophil-lymphocyte ratio correlate with clinical disease activity and progression in patients with benign prostatic hyperplasia?
Population
320 consecutive patients with symptoms of the lower urinary tract, mean age 60 years.
Design
Cross-sectional
Authors
Loading...
NLR may mark BPH severity; cross-sectional data leave open its value for progression monitoring pending prospective studies.
Does the neutrophil-lymphocyte ratio correlate with clinical disease activity and progression in patients with benign prostatic hyperplasia?
The neutrophil-lymphocyte ratio correlates with symptom severity and clinical status in patients with benign prostatic hyperplasia, suggesting its potential utility as a simple marker for disease progression.
Tanık et al. (2014) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: